S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
Journal
BMC cancer
Journal Volume
23
Journal Issue
1
Date Issued
2023-06-06
Author(s)
Abstract
Cancer cachexia, occurring in ~ 80% pancreatic cancer (PC) patients overall, is a paraneoplastic syndrome mediated by cancer-induced systemic inflammation and characterized by weight loss and skeletal muscle wasting. Identifying clinically relevant PC-derived pro-inflammatory factors with cachexigenic potential may provide novel insights and therapeutic strategies.
Subjects
Biomarker; Cachexia; Muscle atrophy; Pancreatic cancer; S100A8; S100A9
Type
journal article